Legal & General Group’s Cabaletta Bio CABA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$34K Buy
+10,918
New +$35.9K ﹤0.01% 2907
2025
Q2
Sell
-3,961
Closed -$5.49K 3435
2025
Q1
$5.49K Hold
3,961
﹤0.01% 3262
2024
Q4
$8.99K Hold
3,961
﹤0.01% 3269
2024
Q3
$18.7K Sell
3,961
-22,759
-85% -$132K ﹤0.01% 3078
2024
Q2
$200K Buy
26,720
+3,302
+14% +$40.5K ﹤0.01% 2668
2024
Q1
$400K Sell
23,418
-2,193
-9% -$47.1K ﹤0.01% 2513
2023
Q4
$581K Sell
25,611
-6,032
-19% -$101K ﹤0.01% 2396
2023
Q3
$482K Buy
31,643
+28,612
+944% +$391K ﹤0.01% 2457
2023
Q2
$39.1K Buy
+3,031
New +$32.9K ﹤0.01% 2902
2021
Q2
Sell
-1,138
Closed -$13K 3506
2021
Q1
$13K Hold
1,138
﹤0.01% 3296
2020
Q4
$14K Hold
1,138
﹤0.01% 3216
2020
Q3
$12K Sell
1,138
-488
-30% -$5.61K ﹤0.01% 3146
2020
Q2
$18K Buy
1,626
+737
+83% +$5.64K ﹤0.01% 3101
2020
Q1
$6K Sell
889
-541
-38% -$7.42K ﹤0.01% 3237
2019
Q4
$20K Buy
+1,430
New +$16.9K ﹤0.01% 3184

Other funds holding CABA

Legal & General Group's CABA Position: Q2 2026 in Review

Legal & General Group opened a new position in Cabaletta Bio (CABA) in Q2 2026: 10,918 shares worth $34K. The stake represents ﹤0.01% of the portfolio and ranks #2907 among its holdings. This is a return to the name: Legal & General Group previously reported a position in CABA as recently as Q1 2025.

Legal & General Group first reported a position in CABA in Q4 2019 and has held it in 15 quarters since. The position peaked at $581K in Q4 2023. 139 funds tracked by Wall St. Rank hold CABA as of Q2 2026.

  • Legal & General Group held 10,918 shares of Cabaletta Bio worth $34K as of Q2 2026.
  • Cabaletta Bio was a new Legal & General Group position in Q2 2026.
  • Cabaletta Bio made up ﹤0.01% of Legal & General Group's portfolio in Q2 2026, its #2907 holding.
  • Legal & General Group first reported a position in Cabaletta Bio in Q4 2019 and has held it in 15 quarters since.
  • Legal & General Group's Cabaletta Bio position peaked at $581K in Q4 2023.
  • 139 funds tracked by Wall St. Rank held Cabaletta Bio as of Q2 2026.

Based on Legal & General Group's 13F filing for Q2 2026, filed 14 Aug 2026.